Basis: FMP quote price / unrounded FMP forward EPS in the trading currency, available after its recorded retrieval time. Source: stored company filings and market data; unavailable inputs remain N/A.
The forward PE ratio is N/A as of 2026-10-06T17:30:20.113Z.
Consensus retrieved: unavailable. This records retrieval, including cache reads, rather than vendor publication. The calculation uses the separately dated price and estimate available at its as-of time.
Calculation as of: 2026-10-06T17:30:20.113Z.
Quote observation: 2026-10-06T17:29:27.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 5c9508078213b28dfeff6809371853141f28b2786ea2d18fc4f82dd6840af9a4
FORWARD PE RATIO
N/A
Advanced Biomed Inc. Common Stock
Market Cap
$9.29M
Forward PE Ratio
N/A
| NAME | MARKET CAP | FORWARD PE RATIO |
|---|---|---|
| Advanced Biomed Inc. Common Stock (ADVB) | $9.29M | N/A |
| SeaStar Medical Holding Corporation (ICU)vs › | $9.37M | N/A |
| NeuroOne Medical Technologies Corporation (NMTC)vs › | $9.57M | N/A |
| Jasper Therapeutics, Inc. (JSPR)vs › | $8.99M | N/A |
| Ainos, Inc. (AIMD)vs › | $9.65M | N/A |
| MetaVia Inc. (MTVA)vs › | $9.88M | N/A |
| DataMEDS AI, Inc. (MEDS)vs › | $8.53M | N/A |
| Medicus Pharma Ltd. Common Stock (MDCX)vs › | $10.10M | N/A |
| Healthcare Triangle, Inc. (HCTI)vs › | $8.36M | N/A |
| Polyrizon Ltd. (PLRZ)vs › | $10.34M | N/A |
Trailing P/E
N/A
reported TTM EPS
Forward P/E
N/A
consensus fiscal-year EPS
PE Ratio = Share Price / Diluted EPS (TTM)
The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
